theblogbox.net
New Treatment Approved for Common Skin Cancer
MONDAY, Oct. 1, 2018 (HealthDay News) -- Libtayo (cemiplimab-rwlc) injection has been approved by the U.S. Food and Drug Administration to treat advanced squamous cell carcinoma (CSCC), the agency said in a news release. The drug is from a class of medications called immune checkpoint inhibitors. T